The group linked to IDIBELL investigates personalized precision strategies for the interdisciplinary approach to heart failure in its evolutionary phases. Their research will contribute to the objective of the CIBERCV: reduce the impact of cardiovascular diseases and develop actions of excellence in translational cardiovascular research and training.
The international group of scientists who have discovered the benefits of dapagliflozin in the treatment of heart failure, including Dr. Josep Comín, head of the IDIBELL BIO-Heart Research Group on Cardiovascular Diseases and the Cardiology Service of the Hospital de Bellvitge, has published new disaggregated results of this research in the leading scientific journals Nature Medicine and the Journal of the American College of Cardiology (JACC).
A study by the Bellvitge Biomedical Research Institute (IDIBELL), the Bellvitge University Hospital, the University of Barcelona, and CIBERSAM observes that children with increased volume of two prefrontal cortex structures respond better to cognitive behavioral therapy.
The Bioimaging Platform of the IDIBELL Scientific-technical Services has incorporated a new high-performance equipment, which is the Carl Zeiss LSM980 confocal microscope equipped with the Airyscan2 detector
Presentation of the new confocal microscope of the Bioimaging platform Read More »
A study led by the Catalan Institute of Oncology and IDIBELL, published in the scientific journal ‘Transplantation and Cellular Therapy’, concludes that, whenever possible, it is better for the patient to receive a transplant from a highly compatible registry donor than from a haploidentical donor with a family relationship, but less compatible.
The donation, the result of the solidarity campaigns organized by the Association throughout 2022, will be used to finance the generation of a new experimental model for the study of predisposition to cancer, a project based on personalized medicine, and the use of stem cells to modeling diseases.
The work focuses on endogenous blood stem cell rejuvenation as a possible strategy to regenerate tissues and improve the health and life expectancy of the elderly.
A drug that boosts the regeneration of stem cells extends life expectancy in mice Read More »
Although further research is needed to determine whether the identification of genetic markers may lead to the development of new targeted treatments, these findings help to understand how these markers may condition the pathology of suicidal thoughts and actions.
Identified four genes that increase the risk of suicidal thoughts and acts Read More »
Today the Niemann-Pick Spain Foundation came to deliver the check for 71,056.25 euros that will fully finance a pilot study to determine the efficacy and safety of the drug Efavirenz to alleviate the cognitive deterioration of patients with this minority disease of genetic origin and for which there is currently no treatment. The event was
This is the largest study on the genetics of colorectal cancer risk. The study, carried out by a global consortium, with the participation of IDIBELL and the Catalan Institute of Oncology, opens new strategies for treatment and chemoprevention.
